Calendar

pharmadog

Week of Mar 9, 2026

Mar 11, 2026approval172d agoBRIMONIDINE TARTRATE — FDA approvalLumify

Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Lumify →fda approvals ↗

Mar 12, 2026approval171d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 12, 2026approval171d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 12, 2026approval171d agoPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

Sponsor: HETERO LABS LTD III. Form: SYRUP. Route: ORAL

full page →PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE →fda approvals ↗

Mar 12, 2026approval171d agoTRULICITY (DULAGLUTIDE) — FDA approvaldulaglutide

Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION

full page →dulaglutide →fda approvals ↗

Mar 12, 2026approval171d agoSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalToujeo LA

Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

full page →Toujeo LA →fda approvals ↗

Mar 12, 2026approval171d agoPOTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC) — FDA approvalHospira Inc

Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 12, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗

Mar 12, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗

Mar 12, 2026approval171d agoADLYXIN (LIXISENATIDE) — FDA approvalADLYXIN

Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ADLYXIN →fda approvals ↗

Mar 12, 2026approval171d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →lenacapavir sodium LA →fda approvals ↗

Mar 12, 2026approval171d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

Sponsor: GILEAD SCIENCES INC. Form: TABLET. Route: ORAL

full page →lenacapavir sodium LA →fda approvals ↗

Mar 12, 2026approval171d agoPOMALIDOMIDE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 12, 2026earnings171d agoScilex Holding Co earningsScilex Holding Co

Anticipated earnings call for Scilex Holding Co ($SCLX).

full page →yahoo earnings ↗

Mar 13, 2026approval170d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Mar 13, 2026approval170d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

full page →Daptomycin Novo →fda approvals ↗

Mar 13, 2026approval170d agoMEFENAMIC ACID — FDA approvalMEFENAMIC ACID

Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

full page →MEFENAMIC ACID →fda approvals ↗

Mar 13, 2026approval170d agoGEMCITABINE HYDROCHLORIDE — FDA approvalGEMCITABINE HYDROCHLORIDE

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →GEMCITABINE HYDROCHLORIDE →fda approvals ↗

Mar 13, 2026approval170d agoALLOPURINOL SODIUM — FDA approvalALLOPURINOL SODIUM

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →ALLOPURINOL SODIUM →fda approvals ↗

Mar 13, 2026approval170d agoALLOPURINOL SODIUM — FDA approvalALLOPURINOL SODIUM

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →ALLOPURINOL SODIUM →fda approvals ↗

Mar 13, 2026approval170d agoMETHOTREXATE — FDA approvalMaxtrex

Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

full page →Maxtrex →fda approvals ↗

Mar 13, 2026approval170d agoPHYTONADIONE — FDA approvalSigyn Therapeutics, Inc.

Sponsor: ORBICULAR. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 13, 2026approval170d agoCITALOPRAM HYDROBROMIDE — FDA approvalCITALOPRAM HYDROBROMIDE

Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

full page →CITALOPRAM HYDROBROMIDE →fda approvals ↗

Week of Mar 16, 2026

Mar 16, 2026approval167d agoNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalrimegepant sulfate ODT

Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →rimegepant sulfate ODT →fda approvals ↗

Mar 16, 2026approval

← prev

page 372 of 392

Week of Mar 9, 2026

Week of Mar 16, 2026